RIVM: seven e-cigarette flavourings with tobacco-taste pose health risk The Dutch government only wants to allow 23 e-cigarette flavourings with a tobacco-taste. RIVM examined whether these 23 flavourings are harmful to people’s health.
From 1 June 2022, heel prick test also screens for muscle disease SMA, bringing number of screened diseases to 26 From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.
Tailor-made information will help immigrants make decisions on taking part in screening programmes Immigrants are relatively less likely to take part in preventive screening programmes, such as cancer screening. This is partly due to the language barrier and a lack of knowledge, according to a doctoral thesis by Nora Hamdiui.
Public opinion: keep society open and continue providing healthcare during COVID-19 surge In the long-term approach to the COVID-19 pandemic, the Dutch government is assigning a key role to civil society and private citizens. When asked what their priorities are in that context, the answer was to prevent delays in surgical interventions.
Number of tuberculosis patients in the Netherlands increased slightly in 2021 compared to 2020 The number of people with tuberculosis (TB) in the Netherlands increased slightly in 2021, reaching 680. This figure is 9% higher than it was in 2020 (622 patients).
New: NEVO online 2021 RIVM published a new online edition of the Dutch food composition database (NEVO).
RIVM to play greater role in tuberculosis control The Committee for Practical Tuberculosis Control (CPT) will be transferred per 1 January 2022 to the National Institute for Public Health and the Environment (RIVM) after a period of 70 years with KNCV Tuberculosis Foundation.
Significant increase in support for and compliance with coronavirus measures Compliance with coronavirus measures such as working from home, distancing and testing if you have symptoms increased during the recent period of high infection rates and hospital admissions.
New WHO Collaborating Centre hosted by RIVM combines laboratory preparedness and biorisk RIVM has been designated WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk by the World Health Organization (WHO).
Wider availability of self-tests leads to higher willingness to test As of Friday 3 December, the recommendation in the Netherlands is to use a self-test in case of mild symptoms, as an alternative to a test by the Municipal Public Health Services (GGDs). Beeld: ANP